- Report
- January 2026
- 197 Pages
Global
From €5214EUR$5,850USD£4,522GBP
- Report
- January 2026
- 194 Pages
Global
From €5214EUR$5,850USD£4,522GBP
- Report
- January 2026
- 181 Pages
Global
From €5214EUR$5,850USD£4,522GBP
- Report
- January 2026
- 194 Pages
Global
From €5214EUR$5,850USD£4,522GBP
- Report
- January 2026
- 186 Pages
Global
From €5214EUR$5,850USD£4,522GBP
- Report
- January 2026
- 192 Pages
Global
From €5214EUR$5,850USD£4,522GBP
- Report
- January 2026
- 186 Pages
Global
From €5214EUR$5,850USD£4,522GBP
- Report
- January 2026
- 196 Pages
Global
From €5214EUR$5,850USD£4,522GBP
- Report
- January 2026
- 194 Pages
Global
From €5214EUR$5,850USD£4,522GBP
- Report
- January 2026
- 179 Pages
Global
From €5214EUR$5,850USD£4,522GBP
- Report
- January 2026
- 504 Pages
Global
From €5214EUR$5,850USD£4,522GBP
- Report
- January 2026
- 269 Pages
Global
From €5214EUR$5,850USD£4,522GBP
- Report
- January 2026
- 192 Pages
Global
From €3511EUR$3,939USD£3,045GBP
- Report
- September 2025
- 250 Pages
Global
From €4002EUR$4,490USD£3,471GBP
- Report
- September 2025
- 250 Pages
Global
From €4002EUR$4,490USD£3,471GBP
- Report
- September 2025
- 250 Pages
Global
From €4002EUR$4,490USD£3,471GBP
- Report
- September 2025
- 250 Pages
Global
From €4002EUR$4,490USD£3,471GBP
- Report
- September 2025
- 250 Pages
Global
From €4002EUR$4,490USD£3,471GBP
- Report
- September 2025
- 250 Pages
Global
From €4002EUR$4,490USD£3,471GBP
- Report
- September 2025
- 250 Pages
Global
From €4002EUR$4,490USD£3,471GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more